CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading

Activated hepatic stellate cells directly induce pathogenic Th17 cells in chronic hepatitis B virus infection

(2017) Yun Liu et al.   EXPERIMENTAL CELL RESEARCH

The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells

(2017) Francesca Virginia Bruschi et al.   HEPATOLOGY

Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling

(2017) Daniel A Giles et al.   NATURE MEDICINE

Lipid droplets and liver disease: from basic biology to clinical implications

(2017) Nina L. Gluchowski et al.   Nature Reviews Gastroenterology & Hepatology

Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease

(2016) Joel T. Haas et al.   Annual Review of Physiology

Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells

(2016) Alexandra M. Hetherington et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease

(2016) Quentin M. Anstee et al.   GASTROENTEROLOGY

Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients

(2016) Andreas Teufel et al.   GASTROENTEROLOGY

Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers

(2016) Ruixin Zhu et al.   JOURNAL OF PATHOLOGY

Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD

(2016) Johannie du Plessis et al.   PLoS One

Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease

(2015) A. Wieland et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Serum macrophage inflammatory protein 3α levels predict the severity of HBV-related acute-on-chronic liver failure

(2015) Jiaojiao Xin et al.   GUT

Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients

(2015) Anthony Petrick et al.   OBESITY SURGERY

Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease

(2015) Bratati Kahali et al.   SEMINARS IN LIVER DISEASE

High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease–related fibrosis

(2015) Fatjon Leti et al.   Translational Research

Genome-wide analysis of hepatic lipid content in extreme obesity

(2014) Johanna K. DiStefano et al.   ACTA DIABETOLOGICA

Roles for Chemokines in Liver Disease

(2014) Fabio Marra et al.   GASTROENTEROLOGY

CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

(2014) Silvia Affò et al.   GUT

Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?

(2014) Bin Gao et al.   GUT

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

(2014) Carlo Pirazzi et al.   HUMAN MOLECULAR GENETICS

Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease

(2014) E Rodríguez-Gallego et al.   INTERNATIONAL JOURNAL OF OBESITY

The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis

(2014) Michael H Miller et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?

(2014) Zoon Tariq et al.   LIVER INTERNATIONAL

Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites

(2014) Witigo von Schönfels et al.   LIVER INTERNATIONAL

Transcriptional regulation of CCL20 expression

(2014) Lifang Zhao et al.   MICROBES AND INFECTION

Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study

(2014) Paola Stiuso et al.   Oxidative Medicine and Cellular Longevity

Obesity, fatty liver disease and intestinal microbiota

(2014) Nur Arslan   WORLD JOURNAL OF GASTROENTEROLOGY

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)

(2013) Giridhar Kanuri et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Dendritic cells in liver injury and fibrosis: Shortcomings and promises

(2013) Veronika Lukacs-Kornek et al.   JOURNAL OF HEPATOLOGY

From fatty liver to fibrosis: A tale of “second hit”

(2013) Metin Basaranoglu   WORLD JOURNAL OF GASTROENTEROLOGY

An electronic health record-enabled obesity database

(2012) G Craig Wood et al.   BMC Medical Informatics and Decision Making

Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis

(2012) Silvia Affò et al.   GUT

Morbid obesity rates continue to rise rapidly in the United States

(2012) R Sturm et al.   INTERNATIONAL JOURNAL OF OBESITY

Standardized bioenergetic profiling of adult mouse cardiomyocytes

(2012) Ryan D. Readnower et al.   PHYSIOLOGICAL GENOMICS

Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes

(2011) Patrick Sauvant et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

(2010) Yaron Rotman et al.   HEPATOLOGY

Chemokines in Liver Inflammation and Fibrosis

(2010) Hermann Wasmuth et al.   SEMINARS IN LIVER DISEASE

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY